Derivative Financial Instruments

6 Months Ended

Mar. 30, 2024

Derivative Instruments and Hedges, Assets [Abstract]

We principally use derivative financial instruments to manage foreign exchange risk related to foreign operations and foreign currency transactions and interest rate risk associated with long-term debt. We enter into derivative financial instruments with a number of major financial institutions to minimize counterparty credit risk.

Derivatives designated as hedging instruments

We use foreign currency contracts as cash flow hedges to effectively fix the exchange rates on future payments and revenue. As of March 30, 2024, we had no outstanding foreign currency contracts.

We use forward currency contracts to hedge our net investment in certain foreign subsidiaries. As of March 30, 2024, we had no outstanding net investment hedges.

Interest rate swaps are used to adjust the proportion of total debt that is subject to variable and fixed interest rates. The interest rate swaps are designated as hedges of the amount of future cash flows related to interest payments on variable-rate debt that, in combination with the interest payments on the debt, convert a portion of the variable-rate debt to fixed-rate debt. At March 30, 2024, we had no outstanding interest rate swaps.

Foreign currency contracts, net investment hedges and interest rate swaps are recorded in the Consolidated Condensed Balance Sheets at fair value and the related gains or losses are deferred in Shareholders’ Equity as a component of Accumulated Other Comprehensive Income (Loss) ("AOCIL"). These deferred gains and losses are reclassified into the Consolidated Condensed Statements of Earnings, as necessary, during the periods in which the related payments or receipts affect earnings. However, to the extent the foreign currency contracts and interest rate swaps are not perfectly effective in offsetting the change in the value of the payments and revenue being hedged, the ineffective portion of these contracts is recognized in earnings immediately. Ineffectiveness was not material in the first six months of 2024 or 2023.

Derivatives not designated as hedging instruments

We also have foreign currency exposure on balances, primarily intercompany, that are denominated in a foreign currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in the Consolidated Condensed Statements of Earnings. To minimize foreign currency exposure, we have foreign currency contracts with notional amounts of $130,012 at March 30, 2024. The foreign currency contracts are recorded in the Consolidated Condensed Balance Sheets at fair value and resulting gains or losses are recorded in the Consolidated Condensed Statements of Earnings. We recorded the following gains and losses on foreign currency contracts which are included in other income or expense and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other income or expense:


		Three Months Ended				Six Months Ended
	Statements of Earnings location	March 30, 2024		April 1, 2023		March 30, 2024		April 1, 2023
Net gain (loss)
Foreign currency contracts	Other	$	(2,919)	$	(890)	$	1,533	$	3,105

Summary of derivatives

The fair value and classification of derivatives is summarized as follows:


	Balance Sheets location	March 30, 2024		September 30, 2023
Derivatives designated as hedging instruments:
Foreign currency contracts	Other current assets	$	—	$	295





Foreign currency contracts	Accrued liabilities and other	$	—	$	581





Derivatives not designated as hedging instruments:
Foreign currency contracts	Other current assets	$	41	$	93
Foreign currency contracts	Accrued liabilities and other	$	445	$	324